MRNO Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$1.14B2021-12-31 → 2025-12-31
EPS$-3.552022-12-31 → 2025-12-31
Net margin-24.8%2023-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
MRNO
5Y avg
Peer Median
Verdict
P/E
-0.25Y avg ≈4.3
≈4.3
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
MRNO
5Y avg
Peer Median
Verdict
EBITDA Margin
25.3%5Y avg ≈38.8%
≈38.8%
·
·
Pretax Margin
-25.0%5Y avg ≈-167.3%
≈-167.3%
·
·
Net Profit Margin
-24.8%5Y avg ≈-164.5%
≈-164.5%
·
·
ROA
-1.4%5Y avg ≈-6.1%
≈-6.1%
·
·
ROE
-7.5%5Y avg ≈-20.5%
≈-20.5%
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
MRNO
5Y avg
Peer Median
Verdict
Current Ratio
0.35Y avg ≈0.3
≈0.3
·
·
Quick Ratio
0.05Y avg ≈0.0
≈0.0
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
MRNO
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-3.555Y avg ≈$3.84
≈$3.84
·
·
Revenue / Share
$14.35
·
·
·
Cash Flow / Share
$1.17
·
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
MRNO
5Y avg
Peer Median
Verdict
Asset Turnover
0.15Y avg ≈0.0
≈0.0
·
·
Revenue / Employee
≈$1.1M
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement12
Metric
Trend
2025
2024
2023
2022
Revenue
$1.14B
$730M
$287M
$6M
SG&A Expense
$1.55B
$1.38B
$608M
$251M
Interest Expense
$1.47B
$797M
$304M
$86M
Interest Income
$14M
$35M
$9M
$555.6K
Pretax Income
$-285M
$-3.50B
$6M
$475M
Income Tax
$-3M
$73M
$-52M
$231M
Net Income
$-282M
$-3.57B
$58M
$244M
EPS (Basic)
$-3.55
$-46.30
$0.84
$64.38
EPS (Diluted)
$-3.55
$-46.30
$0.84
$64.38
Shares (Basic)
79,486,548
77,062,978
69,099,785
69,099,785
Shares (Diluted)
79,486,548
77,062,978
69,099,785
69,099,785
EBITDA
$288M
$320M
$135M
·
Balance Sheet9
Metric
Trend
2025
2024
2023
2022
Cash & Equivalents
$1M
$2M
$993.7K
$434.4K
Inventory
$16M
$11M
$1M
$2M
Current Assets
$3.10B
$1.49B
$597M
$520M
PP&E (Net)
$12.81B
$18.82B
$17.42B
$16.88B
Total Assets
$17.50B
$21.87B
$19.47B
$18.80B
Current Liabilities
$11.93B
$4.36B
$2.63B
$4.07B
Total Liabilities
$15.19B
$16.66B
$11.64B
$10.40B
Retained Earnings
$-5.05B
$-4.77B
$-1.18B
$-1.24B
Stockholders' Equity
$2.31B
$5.21B
$7.83B
$8.40B
Cash Flow5
Metric
Trend
2025
2024
2023
2022
D&A
$288M
$320M
$135M
$2M
Other Non-cash
$87M
$3.15B
$-28M
·
Operating Cash Flow
$93M
$-95M
$165M
$-276M
Investing Cash Flow
$-267M
$-1.08B
$-1.70B
$-1.44B
Financing Cash Flow
$-522M
$2.00B
$1.44B
$1.77B
Profitability5
Metric
Trend
2025
2024
2023
2022
Net Margin
-24.8%
-488.8%
20.2%
·
Pretax Margin
-25.0%
-478.8%
2.0%
·
EBITDA Margin
25.3%
43.8%
47.3%
·
ROA
-1.4%
-17.3%
0.30%
·
ROE
-7.5%
-54.7%
0.71%
·
Liquidity & Solvency2
Metric
Trend
2025
2024
2023
2022
Current Ratio
0.3
0.3
0.2
·
Quick Ratio
0.0
0.0
0.0
·
Efficiency1
Metric
Trend
2025
2024
2023
2022
Asset Turnover
0.1
0.0
0.0
·
Per Share3
Metric
Trend
2025
2024
2023
2022
Revenue / Share
$14.35
$9.47
·
·
Cash Flow / Share
$1.17
$-1.23
·
·
EPS (TTM)
$-3.55
$-46.30
$0.84
·
Valuation (TTM)4
Metric
Trend
2025
2024
2023
2022
Revenue TTM
$1.14B
$730M
$287M
·
Net Income TTM
$-282M
$-3.57B
$58M
·
P/E
-0.2
-0.2
13.3
·
Earnings Yield
-614.2%
-452.1%
7.5%
·
No quarterly filings for MRNO
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$1.14B
$730M
$287M
$6M
$2M
Net Income
$-282M
$-3.57B
$58M
$244M
$-106M
Diluted EPS
$-3.55
$-46.30
$0.84
$64.38
·
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Current Ratio
0.3
0.3
0.2
·
·
Quick Ratio
0.0
0.0
0.0
·
·
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F)
11 filers
· $150K total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders11
Value held$150K
New positions6
Exited positions2
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
6 (+3 vs prior Q)
2 (0 vs prior Q)
1 (-2 vs prior Q)
3 (+3 vs prior Q)
+158K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
My Metrics
Your personal watchlist — selected rows from Full Fundamentals
26
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed May 15, 2026
We use cookies to analyze site traffic and improve your experience.
Learn more
Cookie preferences
NecessaryEssential for basic site functions: language, theme, consent memory.
AnalyticsHelp us understand how visitors use the site. Anonymous traffic data.
MarketingMeasure ad effectiveness and show relevant ads. Google Ads cookies.
PersonalizationPersonalized content and ad recommendations based on your browsing.